Clinical Trial Update: Maternal Serum Pentraxin 3 in Early Pregnancy to Predict Gestational Diabetes Mellitus

View source ↗

Summary

This completed clinical trial investigated whether maternal serum pentraxin 3 measured in early pregnancy can predict gestational diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Snippet

Sponsor: Shanghai First Maternity and Infant Hospital | Conditions: Pregnancy Complications Affecting Fetus (Diagnosis) | Status: COMPLETED